Copyright Reports & Markets. All rights reserved.

Global Biopharmaceutical CMO and CRO Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Biopharmaceutical CMO and CRO Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Contract Manufacturing
      • 1.4.3 Contract Research
    • 1.5 Market by Application
      • 1.5.1 Global Biopharmaceutical CMO and CRO Market Share by Application: 2020 VS 2026
      • 1.5.2 Biologics Manuefacturing
      • 1.5.3 Biosimilars Manuefacturing
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Biopharmaceutical CMO and CRO Market Perspective (2015-2026)
    • 2.2 Biopharmaceutical CMO and CRO Growth Trends by Regions
      • 2.2.1 Biopharmaceutical CMO and CRO Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Biopharmaceutical CMO and CRO Historic Market Share by Regions (2015-2020)
      • 2.2.3 Biopharmaceutical CMO and CRO Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Biopharmaceutical CMO and CRO Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Biopharmaceutical CMO and CRO Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Biopharmaceutical CMO and CRO Players by Market Size
      • 3.1.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue (2015-2020)
      • 3.1.2 Global Biopharmaceutical CMO and CRO Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Biopharmaceutical CMO and CRO Market Concentration Ratio
      • 3.2.1 Global Biopharmaceutical CMO and CRO Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO and CRO Revenue in 2019
    • 3.3 Biopharmaceutical CMO and CRO Key Players Head office and Area Served
    • 3.4 Key Players Biopharmaceutical CMO and CRO Product Solution and Service
    • 3.5 Date of Enter into Biopharmaceutical CMO and CRO Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Type (2015-2020)
    • 4.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2021-2026)

    5 Biopharmaceutical CMO and CRO Breakdown Data by Application (2015-2026)

    • 5.1 Global Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)
    • 5.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Biopharmaceutical CMO and CRO Market Size (2015-2020)
    • 6.2 Biopharmaceutical CMO and CRO Key Players in North America (2019-2020)
    • 6.3 North America Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
    • 6.4 North America Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Biopharmaceutical CMO and CRO Market Size (2015-2020)
    • 7.2 Biopharmaceutical CMO and CRO Key Players in Europe (2019-2020)
    • 7.3 Europe Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
    • 7.4 Europe Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

    8 China

    • 8.1 China Biopharmaceutical CMO and CRO Market Size (2015-2020)
    • 8.2 Biopharmaceutical CMO and CRO Key Players in China (2019-2020)
    • 8.3 China Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
    • 8.4 China Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Biopharmaceutical CMO and CRO Market Size (2015-2020)
    • 9.2 Biopharmaceutical CMO and CRO Key Players in Japan (2019-2020)
    • 9.3 Japan Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
    • 9.4 Japan Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Biopharmaceutical CMO and CRO Market Size (2015-2020)
    • 10.2 Biopharmaceutical CMO and CRO Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

    11 India

    • 11.1 India Biopharmaceutical CMO and CRO Market Size (2015-2020)
    • 11.2 Biopharmaceutical CMO and CRO Key Players in India (2019-2020)
    • 11.3 India Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
    • 11.4 India Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Biopharmaceutical CMO and CRO Market Size (2015-2020)
    • 12.2 Biopharmaceutical CMO and CRO Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
    • 12.4 Central & South America Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 AGC Biologics
      • 13.1.1 AGC Biologics Company Details
      • 13.1.2 AGC Biologics Business Overview and Its Total Revenue
      • 13.1.3 AGC Biologics Biopharmaceutical CMO and CRO Introduction
      • 13.1.4 AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2015-2020))
      • 13.1.5 AGC Biologics Recent Development
    • 13.2 Boehringer Ingelheim International GmbH
      • 13.2.1 Boehringer Ingelheim International GmbH Company Details
      • 13.2.2 Boehringer Ingelheim International GmbH Business Overview and Its Total Revenue
      • 13.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Introduction
      • 13.2.4 Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
      • 13.2.5 Boehringer Ingelheim International GmbH Recent Development
    • 13.3 FUJIFILM Diosynth Biotechnologies
      • 13.3.1 FUJIFILM Diosynth Biotechnologies Company Details
      • 13.3.2 FUJIFILM Diosynth Biotechnologies Business Overview and Its Total Revenue
      • 13.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Introduction
      • 13.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
      • 13.3.5 FUJIFILM Diosynth Biotechnologies Recent Development
    • 13.4 Inno Bio Ventures Sdn Bhd
      • 13.4.1 Inno Bio Ventures Sdn Bhd Company Details
      • 13.4.2 Inno Bio Ventures Sdn Bhd Business Overview and Its Total Revenue
      • 13.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Introduction
      • 13.4.4 Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
      • 13.4.5 Inno Bio Ventures Sdn Bhd Recent Development
    • 13.5 JRS PHARMA
      • 13.5.1 JRS PHARMA Company Details
      • 13.5.2 JRS PHARMA Business Overview and Its Total Revenue
      • 13.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Introduction
      • 13.5.4 JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
      • 13.5.5 JRS PHARMA Recent Development
    • 13.6 Lonza
      • 13.6.1 Lonza Company Details
      • 13.6.2 Lonza Business Overview and Its Total Revenue
      • 13.6.3 Lonza Biopharmaceutical CMO and CRO Introduction
      • 13.6.4 Lonza Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
      • 13.6.5 Lonza Recent Development
    • 13.7 PRA Health Sciences, Inc.
      • 13.7.1 PRA Health Sciences, Inc. Company Details
      • 13.7.2 PRA Health Sciences, Inc. Business Overview and Its Total Revenue
      • 13.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Introduction
      • 13.7.4 PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
      • 13.7.5 PRA Health Sciences, Inc. Recent Development
    • 13.8 ProBioGen AG
      • 13.8.1 ProBioGen AG Company Details
      • 13.8.2 ProBioGen AG Business Overview and Its Total Revenue
      • 13.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Introduction
      • 13.8.4 ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
      • 13.8.5 ProBioGen AG Recent Development
    • 13.9 Rentschler Biopharma SE
      • 13.9.1 Rentschler Biopharma SE Company Details
      • 13.9.2 Rentschler Biopharma SE Business Overview and Its Total Revenue
      • 13.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Introduction
      • 13.9.4 Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
      • 13.9.5 Rentschler Biopharma SE Recent Development
    • 13.10 Samsung BioLogics
      • 13.10.1 Samsung BioLogics Company Details
      • 13.10.2 Samsung BioLogics Business Overview and Its Total Revenue
      • 13.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Introduction
      • 13.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
      • 13.10.5 Samsung BioLogics Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global Biopharmaceutical CMO and CRO status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biopharmaceutical CMO and CRO development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      AGC Biologics
      Boehringer Ingelheim International GmbH
      FUJIFILM Diosynth Biotechnologies
      Inno Bio Ventures Sdn Bhd
      JRS PHARMA
      Lonza
      PRA Health Sciences, Inc.
      ProBioGen AG
      Rentschler Biopharma SE
      Samsung BioLogics

      Market segment by Type, the product can be split into
      Contract Manufacturing
      Contract Research
      Market segment by Application, split into
      Biologics Manuefacturing
      Biosimilars Manuefacturing
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Biopharmaceutical CMO and CRO status, future forecast, growth opportunity, key market and key players.
      To present the Biopharmaceutical CMO and CRO development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Biopharmaceutical CMO and CRO are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now